Exercise Physiology.

OpeningWhy this matters.

Exercise is the single most powerful intervention in the prevention of chronic disease. The data on cardiorespiratory fitness as a mortality predictor is more robust than the data on smoking, blood pressure, or LDL.

The 2018 Mandsager study in JAMA Network Open followed 122,007 patients undergoing exercise treadmill testing. The mortality difference between elite-fitness and below-average-fitness groups was a hazard ratio of 5.04 — larger than the gap between non-smokers and smokers.

The discipline that explains why is exercise physiology: how skeletal muscle, the cardiovascular system, the endocrine system, and the mitochondrial network respond to mechanical loading. This deck covers the major variables (VO₂ max, lactate threshold, fibre type, cardiac output), the training methods that move them, and the contemporary 2020s research.

Chapter IA.V. Hill, 1923.

Archibald Vivian Hill, British physiologist, shared the 1922 Nobel Prize in Physiology or Medicine for work on heat production in muscle. His 1923 paper with Hartley Lupton introduced the concept of maximal oxygen uptake — what we now call VO₂ max — and showed that the limiting factor in endurance was the rate at which oxygen could be delivered to working muscle.

Hill measured oxygen uptake during running on grass tracks at Manchester. He found a plateau: above a certain intensity, oxygen consumption stopped rising even as work continued. The body had hit a ceiling. The deficit was made up by anaerobic metabolism — and was paid back as the "oxygen debt" after exercise.

The framework — aerobic capacity, anaerobic threshold, recovery — is still the backbone of exercise physiology a century on.

Chapter IIThe headline number.

VO₂ max is the maximum rate at which an organism can consume oxygen during incremental exercise, expressed in millilitres per kilogram per minute (ml/kg/min). It integrates cardiac output, oxygen-carrying capacity, capillary density, and mitochondrial respiratory capacity into one number.

Reference points. Untrained 30-year-old male: ~40 ml/kg/min. Untrained female: ~32. Recreational runner: 50. Elite male endurance athletes: 75–85. The all-time recorded peaks belong to cross-country skiers — Bjørn Dæhlie measured 96; Espen Harald Bjerke recorded 96; the contemporary Norwegian Oskar Svendsen measured 97.5 at age 18 in 2012, the highest validated number in the literature.

VO₂ max is roughly 50% genetic (HERITAGE Family Study, 1998) and 50% trainable. It declines ~1% per year after 30 in untrained individuals; well-trained individuals can hold it nearly flat into their 50s and 60s.

Chapter IIILactate, the misunderstood metabolite.

Lactate (lactic acid in its undissociated form) is not a waste product. The 20th-century textbook story — lactate is what muscle produces when it runs out of oxygen, and it causes fatigue — is wrong on both counts.

George Brooks's lactate shuttle hypothesis (1985, refined through the 2000s) reframed lactate as a primary metabolic intermediate. Fast-twitch glycolytic fibres produce lactate continuously, even at rest. Slow-twitch oxidative fibres take it up via monocarboxylate transporters and oxidise it in mitochondria. Lactate is a fuel, not a poison.

The blood lactate concentration is the difference between production and clearance. Lactate threshold — the intensity at which production outstrips clearance and blood lactate begins to rise sharply — is the single most predictive variable for endurance performance, often more so than VO₂ max.

Chapter IVLT1 and LT2.

The lactate curve has two inflection points. LT1 (aerobic threshold; ~2 mmol/L) — the intensity at which blood lactate first rises above resting baseline. Below LT1, training is purely aerobic. LT2 (anaerobic threshold; ~4 mmol/L) — the intensity at which lactate accumulation accelerates non-linearly. Above LT2, performance is time-limited.

The training implication, from the Norwegian endurance tradition: ~80% of training volume below LT1, ~20% above LT2, almost nothing in between. The "polarised" model. Stephen Seiler's research at the University of Agder formalised this from observed practice in elite cross-country skiing, rowing, and distance running.

Chapter VZone 2 training.

The training intensity centred on LT1 — easy enough to hold a conversation, hard enough that you'd rather not. Roughly 60–70% of max heart rate; lactate ~1.7–2.0 mmol/L; perceived exertion 4–5 of 10.

Zone 2 has had a 2020s renaissance, principally through the popularising work of Iñigo San-Millán (University of Colorado) and Peter Attia. The mechanistic claim: Zone 2 selectively stimulates mitochondrial biogenesis in slow-twitch fibres, expands the oxidative pathway, and improves "metabolic flexibility" — the capacity to switch between fat and carbohydrate as fuel.

The recommended dose is large. Elite endurance athletes accumulate 12–20 hours/week in Zone 2. The lay-fitness recommendation that emerged from the Attia podcast — 3–4 sessions of 45–60 min/week — is a low-end approximation. Below that volume, the mitochondrial adaptations are modest.

San-Millán has trained Tour de France winner Tadej Pogačar. The Pogačar protocol is the test case for the protocol's elite ceiling.

Chapter VISlow- and fast-twitch.

Skeletal muscle fibres come in two principal types, distinguished by their myosin heavy chain isoform.

Type I (slow-twitch, oxidative). High mitochondrial density, high capillary density, high myoglobin (the red colour), fatigue-resistant, low peak force. Dominant in postural muscles and in endurance specialists. Marathon runners' soleus muscles can be ~80% Type I.

Type IIa (fast-twitch, oxidative-glycolytic). Intermediate mitochondrial density, fast contraction, moderate fatigue resistance. The trainable middle. Most general athletes.

Type IIx (fast-twitch, glycolytic). Low mitochondrial density, fastest contraction, highest peak force, rapidly fatigable. Sprinter and power-athlete dominant. Usain Bolt's vastus lateralis was reportedly ~80% Type II.

Fibre type is largely genetically determined and can shift between IIa and IIx with training, but the I:II ratio is mostly fixed. Bengt Saltin's biopsy work at Karolinska in the 1970s established the picture.

Chapter VIIThe pump.

Cardiac output (Q) = stroke volume (SV) × heart rate (HR). It's the volume of blood pumped per minute, in litres. At rest, ~5 L/min. At max in untrained adults, ~20 L/min. In elite endurance athletes, 35–40 L/min.

Training increases stroke volume more than max heart rate. The trained heart is larger (eccentric hypertrophy of the left ventricle), fills more completely during diastole, and contracts more forcefully. Resting heart rate drops because each beat moves more blood. Miguel Indurain's resting heart rate during his Tour de France peak was 28 bpm.

VO₂ max is the product of cardiac output × arterio-venous oxygen difference (a-vO₂ diff — the oxygen extracted by tissues). The trained athlete improves both. The Fick equation: VO₂ = Q × (CaO₂ − CvO₂).

Chapter VIIIThe energy organelle.

Mitochondria are the cellular organelles where most ATP is produced. They have their own circular DNA (inherited maternally), arose ~1.5 billion years ago from an endosymbiotic event, and run the electron transport chain that couples substrate oxidation to ATP synthesis.

Endurance training increases mitochondrial volume in trained muscle by 40–100% over 6–12 months. John Holloszy's 1967 paper in Journal of Biological Chemistry first demonstrated this in rats and remains the foundational citation. The signal is principally PGC-1α, a transcriptional co-activator induced by exercise that orchestrates mitochondrial biogenesis.

The 2020s research, partly through San-Millán and partly through David Bishop's group in Melbourne, links mitochondrial function not just to endurance but to insulin sensitivity, lactate handling, and chronic-disease risk. Dysfunctional mitochondria are an upstream feature of metabolic syndrome and Type 2 diabetes.

Chapter IXThree systems.

The body has three pathways to regenerate ATP, each with its own time signature.

All three systems contribute simultaneously; the mix shifts with intensity and duration.

Chapter XResistance training.

Strength training stresses the neuromuscular system through high-force contractions against resistance. Adaptations span neural (improved motor-unit recruitment, rate coding, synchronisation) in the first 4–8 weeks, and structural (myofibrillar hypertrophy, tendon stiffness, bone density) over months to years.

The dose-response literature, principally Brad Schoenfeld's research at Lehman College, converges on: 10–20 hard sets per muscle group per week for hypertrophy; 3–6 sets at 80–90% 1RM for maximal strength; protein intake of 1.6–2.2 g/kg/day to support muscle protein synthesis.

The Schoenfeld 2017 meta-analysis in Sports Medicine found the load range from 30% to 90% 1RM produced equivalent hypertrophy, given training to failure. Strength gains, in contrast, are load-specific — heavier loads produce larger 1RM increases.

Chapter XIThe age curve.

From around age 30, untrained adults lose ~1% of muscle mass and ~2–3% of strength per year. The acceleration after 60 — sarcopenia — is the single largest contributor to the falls, fractures, and loss of independence that define late-life disability.

The mechanism is multi-factorial. Anabolic resistance (older muscle responds less to a given protein/leucine signal). Reduced motor neuron numbers. Type II fibre atrophy (the fast-twitch fibres preferentially shrink). Mitochondrial decline. Reduced physical activity, which compounds all of the above.

The intervention that works is resistance training. Maria Fiatarone's 1990 JAMA study showed octogenarian nursing-home residents could increase strength 174% in eight weeks of progressive resistance training. The frailty literature has only strengthened the case in the decades since. Walking, while better than nothing, does not arrest sarcopenia. Loaded movement does.

Chapter XIIIntervals.

High-intensity interval training: short bouts of near-maximal effort separated by recovery. The Tabata protocol (1996) — 8 × 20 s all-out / 10 s rest — is the canonical extreme; most useful HIIT in practice runs 4 × 4 minutes at 90–95% HRmax, the protocol Jan Helgerud and the Norwegian School of Sport Sciences popularised.

HIIT improves VO₂ max more efficiently per minute than moderate continuous training. Helgerud's 2007 study showed 4 × 4 outperformed equivalent-energy moderate training in trained subjects. The mechanism is thought to be the high cardiac output and high motor-unit recruitment that interval intensity demands.

The trade-off: HIIT is metabolically and neurologically expensive. Two to three sessions per week is the upper limit for most athletes. The polarised model uses HIIT as the high-intensity 20%, with Zone 2 carrying the volume.

Chapter XIIIStructuring the year.

Periodisation: the deliberate variation of training stimulus across weeks, months, and years. The framework dates to the Soviet sport-science tradition — Leonid Matveyev's 1965 textbook is the foundational reference.

The classic linear model: progressive overload from general endurance through specific endurance to peak speed/power. Modern variants — block periodisation (Issurin), undulating periodisation, polarised periodisation — vary the sequencing.

The principle that has held up: vary the stimulus. Continuous identical training stops producing adaptation; the body acclimates and the stress signal flattens.

Chapter XIVThe four-minute mile.

Roger Bannister broke 4:00 for the mile on 6 May 1954 at Iffley Road, Oxford — 3:59.4. He was 25, a junior doctor at St Mary's Hospital. The barrier had stood for nine years since Gunder Hägg's 4:01.4. Within 46 days, John Landy ran 3:57.9. Within a decade, the record was 3:54.1.

The Bannister story is partly about the mile. It's principally about the psychology of physiological barriers. The "Bannister effect" — the rapid collapse of a perceived limit once it has been broken — has been argued (with mixed evidence) to operate across sport. Eliud Kipchoge's 1:59:40 marathon (Vienna 2019, unofficial; a paced exhibition) and the subsequent Kelvin Kiptum 2:00:35 (Chicago 2023, official; record-setting) replay the same dynamic.

Bannister himself, asked how he ran it, offered a physiologist's answer: "It's the brain that runs the race." His later academic career was in neurology.

Chapter XVHR and HRV.

Resting heart rate is a crude but useful fitness marker. The classic "220 − age" maximum heart rate formula is an approximation with substantial error (±10–15 bpm); Tanaka's 2001 revision (208 − 0.7 × age) tracks better but still misses individual variation by ~7 bpm at the 95% confidence interval.

Heart rate variability — the beat-to-beat variation in R-R intervals — is a marker of parasympathetic (vagal) tone. High HRV correlates with recovery; low HRV with stress, illness, or overtraining. The smartwatch revolution has put HRV measurement on millions of wrists.

The HRV literature, principally led by Daniel Plews and Andrew Flatt, supports its use as a daily readiness signal. Persistently suppressed HRV over 5–7 days is a stronger overtraining indicator than any single morning's value. The clinical correlations — low HRV predicts cardiovascular events independent of resting HR — are robust across decades of cardiology research.

Chapter XVISleep, food, time.

Adaptation happens during recovery, not during training. The big three.

Sleep. The most powerful and most under-used recovery tool. Eight hours minimum for athletes; nine is better. Acute sleep deprivation impairs glycogen resynthesis, attenuates muscle protein synthesis, raises perceived exertion, and degrades cognitive performance. Cheri Mah's Stanford basketball study (2011) showed extending sleep to 10 hours/night improved sprint and free-throw performance measurably.

Nutrition. Adequate calories, protein 1.6–2.2 g/kg, carbohydrate 5–10 g/kg for endurance athletes (more for high-volume training), micronutrient sufficiency. The post-exercise anabolic window is wider than once claimed (24+ hours) but the practical case for protein within ~2 hours of training holds.

Time. Adaptation takes weeks. Most overtraining failures are from compressing what should be a six-month adaptation curve into six weeks.

Chapter XVIIThe training cliff.

Overtraining syndrome is real and rare. The intermediate state — functional overreaching (intentional, recovers in days) and non-functional overreaching (unintentional, recovers in weeks) — is more common.

Symptoms cluster: persistent fatigue, performance decline despite continued training, sleep disturbance, mood changes (irritability, depression), suppressed HRV, elevated resting heart rate, frequent illness, loss of training drive. Female athletes may experience menstrual disruption. The HPA-axis dysregulation hypothesis (cortisol elevation, then suppression) has partial support.

The fix is rest. The literature on supplements, ice baths, massage, and other recovery modalities for overtraining is weak. Two to four weeks of substantially reduced training load resolves most cases of overreaching. True overtraining syndrome — where months of rest are required — is uncommon outside elite sport.

Chapter XVIIIFemale physiology.

The dominant exercise-physiology literature was built on male subjects through the 1970s and into the 1990s. The historical defaults — fluid balance, thermoregulation, fuel use, training response — were tuned to male reference data. Stacy Sims's 2016 Roar and the 2020s research wave have pushed female-specific work back into the mainstream.

The findings that have held up. Women carry a higher body-fat percentage at equivalent fitness; they oxidise more fat at moderate intensities; their thermoregulation differs in the luteal vs follicular phases. Resistance training response is similar to males in relative terms. Endurance training response, similar.

The clinical concern: RED-S (Relative Energy Deficiency in Sport), the renamed and broadened "Female Athlete Triad." Insufficient energy availability suppresses reproductive function, bone formation, and immune function. Bone-density loss in chronically under-fueled female athletes is largely irreversible.

Chapter XIXThe two big environmental stresses.

Heat acclimation. Repeated exposure to exercise in hot conditions (~5–14 days) drives plasma volume expansion, sweat-rate increases at lower core temperatures, and reduced perceived exertion. Heat training has small but real performance benefits even in temperate-condition events — partly through plasma volume.

Altitude. Exposure to hypoxia stimulates erythropoietin (EPO) production and red cell mass expansion over weeks. The sweet spot for altitude training is ~2,000–2,500 m for 3–4 weeks. Higher altitudes degrade training quality (you can't train hard); lower altitudes don't provide the hypoxic stimulus.

The "live high, train low" model — sleep at altitude, train at sea level — was popularised by Benjamin Levine and Jim Stray-Gundersen in the 1990s. It captures the haematological benefit without the training-quality loss. The Norwegian and Kenyan endurance traditions exploit it heavily; the literature largely supports the practice.

Chapter XXThe shadow.

The pharmacological versions of the natural adaptations. Erythropoietin (recombinant EPO) — boosts red cell mass; the Lance Armstrong scandal centred here. Testosterone and anabolic steroids — accelerate muscle protein synthesis and strength gains. Growth hormone — debated effect on adult performance, though widely used. Beta-2 agonists (clenbuterol, salbutamol) — bronchodilation and lipolysis.

The performance enhancement is real and substantial. The Festina affair (1998 Tour de France) and the Operación Puerto (2006 Spanish cycling) revealed near-universal EPO use in pro cycling. The post-2008 biological passport regime cut into the practice; cycling's top times in 2010s grand tours are slower than the 1990s peaks.

The 2020s era is dominated by uncertainty about gene therapy, mitochondrial modulators, and SARMs. The detection arms race continues.

Chapter XXIThe 2020s popularisers.

Peter Attia, MD. Surgical training at Johns Hopkins; longevity-focused practice in Austin. His Outlive (2023) and the Drive podcast have brought VO₂ max, Zone 2, and grip strength into the lay-fitness vocabulary. The "Centenarian Decathlon" framing — train now for the physical tasks you want to perform at 90 — has been particularly influential.

Iñigo San-Millán, PhD. Exercise physiologist at the University of Colorado, formerly at Garmin–Slipstream and now coach to UAE Team Emirates' Tadej Pogačar. His emphasis on lactate-guided Zone 2 training and metabolic flexibility shaped the popular framing of the topic.

The substance behind the popularisation is solid. The risk is overprescription — turning a population-level health message into a regimented elite-athlete protocol the typical reader doesn't have time for.

Chapter XXIIThe grip-strength signal.

Muscular strength predicts all-cause mortality independent of cardiorespiratory fitness. The marker that emerged from the meta-literature is grip strength — cheap to measure, surprisingly powerful predictor.

The PURE study (Leong et al., Lancet 2015) followed 142,861 adults across 17 countries. A 5-kg lower grip strength associated with a 16% higher all-cause mortality risk and a 17% higher cardiovascular mortality risk. The signal held after adjustment for traditional risk factors.

The question — does building grip strength reduce mortality, or is grip strength a marker of underlying healthy biology — remains partly open. The Mendelian randomisation work and the resistance-training-intervention literature suggest the causal arrow goes both ways: grip strength is partly a marker, but resistance training that builds it does have independent health benefits.

The practical takeaway is uncomplicated: train your strength along with your aerobic capacity. Both matter; the second has been over-emphasised.

Chapter XXIIIMobility and flexibility.

The pre-2010s consensus — static stretching before exercise prevents injury — has not held up. The meta-literature (Behm and Chaouachi, 2011 onwards) shows static stretching transiently reduces strength and power output and has no demonstrated injury-prevention benefit when used as a warm-up.

What does work as a warm-up: dynamic mobility — leg swings, lunges, A-skips — and progressive sport-specific intensity. The "RAMP" framework (Raise, Activate, Mobilise, Potentiate) used in elite team sports is a reasonable template.

Static stretching has a place — at the end of training, or as a separate flexibility-focused session — for athletes whose sport requires extreme range of motion (gymnastics, dance, Olympic lifting). For general fitness, the evidence base for routine static stretching is thin. Strength training through full range of motion delivers most of the same flexibility benefits.

Chapter XXIVThe data revolution.

The 2010s wearables revolution put physiological measurement on the wrist. Garmin, Whoop, Oura, Apple Watch, and Polar collectively brought continuous heart rate, HRV, sleep staging, GPS-paced training load, and recovery metrics out of the laboratory.

The good news. Continuous data permits patterns invisible at the per-session level: chronic vs acute training load, HRV trends, sleep-debt accumulation. The TrainingPeaks "TSS" (Training Stress Score) and Whoop "strain" frameworks operationalise this for non-elite users.

The cautions. Optical heart rate (LED-based) measurement on the wrist has higher error than chest-strap ECG, particularly during high-intensity intervals. Sleep-stage detection is imprecise. "Recovery scores" are derivative rollups whose proprietary weightings are often not transparent. The data is worth using; the algorithm-driven daily prescriptions ("today's recovery is 67%") deserve mild skepticism.

Chapter XXVExercise and the heart.

The cardiovascular benefits of exercise are well-established. The marginal-risk question — does extreme endurance training carry cardiac costs — is more contested.

The "athlete's heart" — eccentric LV hypertrophy, increased chamber size, low resting HR — is a benign training adaptation. The U-shaped mortality curve at very high lifetime exercise volumes (the so-called "exercise paradox") has appeared in some observational studies and not in others. The current consensus: extreme volumes (>20 hours/week sustained over decades) may slightly elevate risk for atrial fibrillation and coronary calcium, but all-cause mortality remains favourable.

The cases that warrant clinical attention. Exercise-induced syncope or chest pain. New onset atrial fibrillation in middle-aged endurance athletes. Family history of premature sudden cardiac death. The American College of Cardiology's 2020 guidance is the operational reference for the screening question.

Chapter XXVIHow little is enough.

The literature on minimum effective dose is one of the most useful for the lay reader. The headline numbers.

Mortality reduction begins at very low doses. The Wen et al. Lancet 2011 study of 416,000 Taiwanese adults showed 15 minutes of daily moderate exercise reduced all-cause mortality 14% versus inactive controls. The dose-response curve continues — diminishing but still positive — to ~60 min/day.

The WHO 2020 guidance: 150–300 min/week of moderate aerobic activity, or 75–150 min/week of vigorous, plus 2 days/week of muscle strengthening. Most adults do less.

Steps per day. The 10,000-step number is a 1960s Japanese pedometer marketing artifact, not a research finding. The Paluch et al. 2022 meta-analysis found mortality benefit plateaus at ~7,500–8,000 steps/day in adults under 60, and at ~6,000–8,000 in older adults.

The minimum-effective-dose case is robust. The marginal-extra-benefit case is real but smaller than headlines suggest.

Chapter XXVIITwenty essentials.

• 1923Muscular Exercise, Lactic Acid, and the Supply and Utilisation of OxygenA.V. Hill
• 1965Periodisation of Sports TrainingMatveyev
• 1967Effects of Exercise on Skeletal Muscle MitochondriaHolloszy
• 1985The Lactate Shuttle HypothesisBrooks
• 1990High-Intensity Strength Training in NonagenariansFiatarone et al.
• 1996Effects of Moderate-Intensity Endurance and High-Intensity Intermittent Training on Anaerobic Capacity and VO₂ maxTabata et al.
• 1998HERITAGE Family StudyBouchard et al.
• 2007Aerobic High-Intensity Intervals Improve VO₂ maxHelgerud et al.
• 2010What is Best Practice for Training Intensity DistributionSeiler
• 2014Endurance Training and the MitochondrionBishop et al.
• 2015Grip Strength and Mortality (PURE)Leong et al.
• 2016RoarSims
• 2017Dose-Response Relationship Between Weekly Resistance Training and HypertrophySchoenfeld et al.
• 2018Cardiorespiratory Fitness and Long-Term MortalityMandsager et al.
• 2018The Endurance DietFitzgerald
• 2019EndureHutchinson
• 2020WHO Physical Activity GuidelinesWHO
• 2022Daily Steps and All-Cause Mortality (Meta)Paluch et al.
• 2023OutliveAttia
• 2024The Science and Practice of Strength Training (3rd ed.)Zatsiorsky & Kraemer

Chapter XXVIIIWatch & read.

↑ San-Millán & Attia · Zone 2 training: dose, frequency, duration

More on YouTube

Watch · VO₂ and oxygen consumption explained · Corporis
Watch · The science of muscle hypertrophy